Reported studies have demonstrated that GABPB1 may have carcinogenic or anticancer roles in different tumor contexts and has the potential for use as a therapeutic target in glioblastoma and bladder cancer [14–16]. This evidence concerns the gene GABPB1 and neoplasm.